checkAd

     101  0 Kommentare Parenteral Formula Market to Reach US$ 12.5 Billion by 2034 Amid Rising Prevalence of Cancer, AIDS, and Diabetes - Seite 2

    The parenteral formula market is mainly pushed by rising chronic illnesses like HIV, Crohn's disease, and cancer. The market is also augmented by extensive research & development efforts of leading firms to create new parenteral nutrition products.

    Scope of the Parenteral Formula Market Report

    Attribute

    Details

    Parenteral Formula Market Size (2024)

    US$ 6.8 billion

    Parenteral Formula Market Forecast Value (2034)

    US$ 12.5 billion

    Global Growth Rate

    5.7% CAGR

    Forecast Period

    2024 to 2034

    Historical Data Available for

    2019 to 2023

    Market Analysis

    US$ billion for Value

    Key Countries Covered

    •  United States

    •  Brazil

    •  Mexico

    •  Germany

    •  UK

    •  France

    •  Italy

    •  Spain

    •  Nordic

    •  Poland

    •  China

    •  India

    •  Thailand

    •  Indonesia

    •  Russia

    •  Canada

    •   Australia and New Zealand

    •  Japan

    •  GCC countries

    Seite 2 von 6



    PR Newswire (engl.)
    0 Follower
    Autor folgen
    Verfasst von PR Newswire (engl.)
    Parenteral Formula Market to Reach US$ 12.5 Billion by 2034 Amid Rising Prevalence of Cancer, AIDS, and Diabetes - Seite 2 NEWARK, Del., March 27, 2024 /PRNewswire/ - Look out for a growing market in Parenteral Formulas (delivered intravenously for nutrition) FMI predicts a surge due to rising malnutrition and preterm births worldwide (2024-2034). The report offers a …